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6Tiivistelmä, Finnish summary
‘D-vitamiinitilanteen merkitys kalsiumin ja luun aineenvaihdunnassa’
Suomessa, jossa väestön D-vitamiinitilanne vaihtelee kausiluontoisesti, D-
vitamiinin puutteen riskiryhmiä ovat mm. pienet lapset ja vanhukset. Seerumin 25-
hydroksi-D-vitamiinipitoisuus (25OHD) kuvastaa D-vitamiinitilannetta siten, että
alhainen 25OHD-pitoisuus viittaa D-vitamiinin puutteeseen. D-vitamiinin puutteen
seuraus on lapsilla riisitauti ja aikuisilla nk. osteomalasia, jolloin luusto ei mineralisoidu
normaalisti. Lievään D-vitamiinin puutteeseen liittyviä luu- ja kalsiumaineenvaihdunnan
muutoksia on tutkittu vähän. Tiedetään, että D-vitamiinin puutteessa
lisäkilpirauhashormonin (PTH) määrä seerumissa lisääntyy. Syntyy sekundaarinen
hyperparatyreoosi, joka lisää luun aineenvaihduntaa. Tässä tutkimuksessa selvitettiin D-
vitamiinitilanteen vaikutuksia kasvuikäisten nuorten (tutkimusaineisto n=231) ja
nuorten aikuisten (tutkimusaineisto n=328) kalsium- ja luuaineenvaihduntaan.
Kasvissyöjien 25OHD-pitoisuuksien tiedetään olevan talvella alhaisia, joten alhaisen D-
vitamiinitilanteen (tutkimusaineisto n=28) ja D-vitamiinilisäyksen (tutkimusaineisto
n=20) merkitystä kasvissyöjien kalsium- ja luuaineenvaihduntaan tutkittiin. Lisäksi
kehitettiin menetelmä D-vitamiinin hyväksikäytettävyyden tutkimiseksi elintarvikkeista,
ja tutkittiin D-vitamiinin imeytymistä ihmisillä (tutkimusaineisto n=27)
pakkaskuivatuista, jauhetuista suppilovahveroista.
Tutkimukset osoittivat, että keskimääräinen päivittäinen D-vitamiinin saanti
ravinnosta oli lähes nykyisten suositusten mukaista sekä nuorilla että aikuisilla, mutta
kasvissyöjien D-vitamiinin saanti ravinnosta oli alhainen. Terveille aikuisille
määritettyjen viitearvojen perusteella ~14% etelä-suomalaisista nuorista ja ~27%
aikuisista kärsi vakavasta D-vitamiinin puutteesta talvella (seerumin 25OHD pitoisuus
alle 25 nmol/l). Seerumin 25OHD- ja PTH-pitoisuuksien välisen yhteyden perusteella
alentunut D-vitamiinitilanne havaittiin ~60% nuorista ja ~70% nuorista aikuisista.
Kasvissyöjien seerumin 25OHD-pitoisuudet olivat myös alhaisia. Tulokset antavat
viitteitä siitä, että talvella alhaisesta D-vitamiinitilanteesta kärsivillä nuorilla, aikuisilla
ja kasvissyöjillä on alhaisempi luun mineraalitiheys kuin henkilöillä, joiden D-
vitamiinitilanne on hyvä läpi vuoden. D-vitamiinihoidon vaikutusta luun
aineenvaihduntaan tutkittiin kasvissyöjillä, joilla 11 kuukauden D-vitamiinihoidon
havaittiin tasapainottavan kalsiumin ja luun aineenvaihduntaa. Metsäsienistä
suppilovahveron tiedetään olevan hyvä D-vitamiinin lähde, ja tässä tutkimuksessa
osoitettiin, että pakkaskuivatuista, jauhetuista suppilovahveroista D-vitamiini imeytyi
yhtä hyvin kuin D-vitamiinivalmisteesta. Tutkimus osoitti, että D-vitamiinin puute on
Suomessa talvella yleistä, joten D-vitamiinilisää suositellaan talvella henkilöille, joiden
D-vitamiinin saanti ravinnosta jää alhaiseksi. Vaihtoehtoisesti D-vitaminoitujen
elintarvikkeiden lukumäärää voisi tämän tutkimuksen perusteella lisätä.
7Abstract
The vitamin D status of people changes from higher summer to lower winter
values in Finland. Especially small children and elderly people are at a risk for  vitamin
D deficiency in the winter. The serum 25-hydroxyvitamin D (25OHD) concentration is
considered to be a good indicator of vitamin D status. Vitamin D deficiency is known to
lead to rickets in children and osteomalacia in adults. There has been only a few studies
investigating the effect of mild vitamin D deficiency on calcium and bone metabolism
among healthy adolescents and young adults. Earlier it has been reported that the
secretion of parathyroid hormone (PTH) is elevated in vitamin D deficiency, and this
secondary hyperparathyroidism is known to increase bone metabolism. In this study the
vitamin D status, calcium and bone metabolism in adolescents (n=231 in total) and in
young adults (n=328 in total) were studied. Earlier studies have shown that vegetarians
suffer from vitamin D deficiency during winter. Thus, the effect of low vitamin D status
(n=28 in total) and vitamin D supplementation (n=20 in total) on calcium and bone
metabolism in vegetarians was also studied. In addition, the bioavailability of vitamin D
from edible mushrooms (Cantharellus tubaeformis) was evaluated (n=27 in total) with a
human bioassay, which was developed in this study.
Regardless of the fact that the mean dietary vitamin D intake practically fulfilled
the recommendations, this study showed that on an average ~14% of adolescents and
~27% of adult Finnish population in southern Finland were vitamin D deficient, having
serum 25OHD concentration less than 25 nmol/l. Moreover, a large percentage of
adolescent (~60%) and adult populations (~70%) had low vitamin D status during
winter in Finland (based on the relation between serum 25OHD and PTH
concentrations). In line with earlier findings the study confirmed that vegetarians
suffered from vitamin D deficiency during winter. These studies suggest that decreased
wintertime vitamin D status negatively affects bone metabolism of healthy adolescents
and adults as well as vegetarians. The effect of vitamin D supplementation on bone
metabolism was studied in vegetarians, in whom 11 months vitamin D supplementation
seemed to normalise disturbances seen in calcium and bone metabolism. Vitamin D was
well absorbed from lyophilised and homogenised mushrooms, Cantharellus
tubaeformis, which can be recommended as a natural source of vitamin D. The
bioavailability of vitamin D from foods can be conveniently studied in humans with the
bioassay developed in the study. To conclude, this study revealed that vitamin D
deficiency is common in Finland in the winter. Thus, in the case that dietary vitamin D
intake is too low, vitamin D supplementation is recommended for adolescents, adults
and vegetarians during winter. Also, the selection of foodstuffs fortified with vitamin D
could be broadened.
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Abbreviations
1,25(OH)2D 1,25-dihydroxyvitamin D
25OHD 25-hydroxyvitamin D
ANCOVA analysis of covariance
ANOVA analysis of variance
BMC bone mineral content
BMD bone mineral density
BMI body mass index
CPBA competitive protein binding assay
DBP vitamin D binding protein
DEXA dual energy x-ray absorptiometry
FFQ food frequency questionnaire
HPLC high-performance liquid chromatography
IRMA immunoradiometric assay
IU   international unit; 40 IU of vitamin D=1 µg of vitamin D
PTH parathyroid hormone; iPTH=intact parathyroid hormone
RIA radioimmunoassay
SD standard deviation
SEM standard error of mean
VDR vitamin D receptor
vitamin D2 ergocalciferol
vitamin D3 cholecalciferol
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1. Introduction
Vitamin D is the major regulator of calcium metabolism and an important determinant
of bone health. The main function of vitamin D is to maintain calcium homeostasis by
increasing intestinal calcium absorption. In vitamin D deficiency calcium absorption and
serum calcium concentration are decreased and the secretion of parathyroid hormone,
PTH, is increased. Increased serum PTH concentrations, in turn, lead to increased bone
resorption. Two well known consequences of prolonged vitamin D deficiency are rickets
in children and osteomalacia in adults. In elderly women even mild vitamin D
deficiency with elevated serum PTH concentrations has been shown to have negative
effects on bone metabolism (Krall et al 1989, Dawson-Hughes et al 1991). However, the
effect of low vitamin D status on growing and ageing skeletons has not been studied in
population-based samples, although it has been suggested that in order to reach maximal
prevention against osteoporosis or other disorders of bone metabolism in the elderly,
bone turnover should be in balance throughout puberty and adulthood.
There have been a few studies of the effect of a vegetarian lifestyle on bone metabolism
over the last few decades. Some of these studies support the hypotheses that a vegetarian
diet may prevent disorders of bone metabolism (Marsh et al 1983), others have not
reported any differences (Hunt et al 1989, Tesar et al 1992). Recently, Barr et al (1998)
reported that vegetarian women tended to have lower lumbar spine bone mineral density
(BMD) than nonvegetarians. However, none of these studies have closely investigated
the effect of vitamin D on the bone metabolism of vegetarians. In our earlier studies we
have shown that Finnish vegetarians suffer from vitamin D deficiency during winter
(Lamberg-Allardt et al 1993, Outila et al 1998).
In this study we further evaluated the effect of low vitamin D status on calcium and
bone metabolism of vegetarians. In addition, although studies done among the elderly
have revealed that vitamin D supplementation has beneficial effects on bone mass (for a
review see Compston 1995), the effect of vitamin D supplementation on bone
metabolism of subjects suffering from vitamin D deficiency has not been studied to a
larger extent.
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The main dietary vitamin D sources in Finland are fish and fortified margarines
(Lamberg-Allardt 1984, Mattila 1995). Some wild mushrooms, especially Cantharellus
tubaeformis, contain relatively high amounts of vitamin D2. For some groups of people,
such as vegetarians or persons allergic to fish, mushrooms could be a potential natural
dietary sources of vitamin D. However, the bioavailability of vitamin D from natural
foods has not been studied. Thus, a bioassay for human vitamin D bioavailability studies
has to be developed, and the bioavailability of vitamin D from natural foods should be
studied.
15
2. Literature review
Vitamin D
Chemical structure, preforms and metabolites of vitamin D compounds
The term ‘vitamin D’ is a generic name for a group of closely related secosteroids with
antirachitic properties. The best-known forms of vitamin D are cholecalciferol (D3) and
ergocalciferol (D2). D3 is the main form of vitamin D in foods of animal origin, and D2
is the major form of vitamin D in plants (Figure 2.1.). It has been evident since the
beginning of 20th century that in vertebrates vitamin D3 is produced also endogenously
by UVB-light (290-315 nm) from the cholesterol-like precursor, 7-dehydrocholesterol,
present in the skin epidermis. Thus, in a strict sense, vitamin D is an essential nutrient
only when sunlight exposure is limited. Vitamin D2 and D3 are both biologically
inactive themselves but after hydroxylations in the liver and kidney they become
biologically active. Although it has been shown that the absorption of vitamin D3 is
better than vitamin D2 (Trang et al 1998), active vitamin D2 and vitamin D3 metabolites
are, however, assumed to have the same biological activity in humans. In this review, no
attempt was made to distinguish between D2 and D3 because such a distinction is not
always made in the literature.
After being absorbed, vitamin D is transported to the liver, where the enzyme 25-
hydroxylase regulates the 25-hydroxylation and the production of 25-hydroxyvitamin D
(25OHD). The production of 25OHD is dependent on substrate concentration and serum
25OHD is an indicator of vitamin D status (De Luca 1979). In the kidney the enzyme 1-
α-hydroxylase converts 25OHD to 1,25-dihydroxyvitamin D [1,25(OH)2D], which is the
active metabolite of vitamin D (for a review see Horst and Reinhardt 1997). The
biological half-life for 25OHD is 20-30 days and for 1,25(OH)2D 4-6 hours (Haddad
and Rojanasathit 1976, Kawakami et al 1979, Clements et al 1992). When 1,25(OH)2D
is in excess, 25OHD is converted in the kidneys to the biologically inactive 24,25-
dihydroxyvitamin D [24,25(OH)2D] by enzyme 24-hydroxylase. 25OHD can be
converted to other vitamin D metabolites, such as 25,26(OH)2D and 1,24,25(OH)3D, but
their physiological roles in the vitamin D endocrine system are not well established (for
a review see Horst and Reinhardt 1997). Around 50 vitamin D metabolites have been
isolated (Ikekawa and Ishizuka 1992), and all circulating metabolites of vitamin D are
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transported by vitamin D binding protein (DBP). However, DBP has the highest relative
affinity for 25OHD (van den Berg 1997).
a)
provitamin D3  vitamin D3           25-hydroxyvitamin D3          1,25-dihydroxyvitamin D3
b)
provitamin D2 vitamin D2      25-hydroxyvitamin D2        1,25-dihydroxyvitamin D2
Figure 2.1.
a) Provitamin D3 (7-dehydrocholesterol, found in animal tissue) is converted by UV-light and heat to
vitamin D3 (cholecalciferol), which is further metabolised in the liver into 25-hydroxyvitamin D3
(25OHD3, calcidiol). In the kidneys 25-hydroxyvitamin D3 is converted into 1,25-dihydroxyvitamin D3
[1,25(OH)2D3, calcitriol].
b) Provitamin D2 (ergosterol, found in plant tissue) is converted to vitamin D2 (ergocalciferol) in the
presence of UV-light. This is hydroxylated to 25-hydroxyvitamin D2 (25OHD2, ercalcidiol) in the liver
and 1,25-dihydroxyvitamin D2 [1,25(OH)2D2, ercalcitriol] in the kidneys.
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Absorption and function of vitamin D
The absorption of vitamin D occurs in the jejunum and ileum by a non-saturable passive
diffusion process with the efficiency of 60 to 90% (for a review see van den Berg 1997).
There is no evidence that vitamin D absorption is affected by the vitamin D status
(Fraser 1983). Holmberg et al (1990) reported that long-chain fatty acids facilitate
vitamin D absorption. In contrast, others have suggested that a high fibre diet enhances
the elimination of vitamin D (Batchelor and Compston 1983). Like other fat soluble
vitamins, dietary vitamin D is transported with chylomicrons and lipoproteins, and
cutaneous vitamin D is transported with DBP into the liver (Haddad et al 1993). Bile is
the main route for vitamin D excretion (Gascon-Barre 1986). Adipose tissue and muscle
are the major storage sites of non-hydroxylated vitamin D in man, liver as well as some
other tissues contain some 25OHD (Mawer et al 1972, De Luca 1979, Fraser 1980).
The most important physiological function of 1,25(OH)2D is to stimulate intestinal
calcium and phosphate absorption. In addition to intestine, the other classical target
organ for 1,25(OH)2D is bone, which also have a crucial role in regulating serum
calcium and phosphate metabolisms (Figure 2.2.). As normal physiological
concentrations of serum calcium and phosphate preserve neuromuscular and cellular
functions, the production of 1,25(OH)2D in the kidney is tightly regulated.
Hypocalcemia leads to increased secretion of PTH and the production of 1,25(OH)2D.
Hypophosphatemia also increases the production of 1,25(OH)2D. Thus, PTH is the main
hormone regulating 1,25(OH)2D production by a negative feedback mechanism
(Garabedian et al 1972). Also other hormones and factors, such as calcitonin, sex
steroids, growth hormones and glucocorticoids, regulate 1,25(OH)2D formation, but
their role in the vitamin D endocrine system is not as well established as the effects of
PTH. In target tissues the actions of 1,25(OH)2D are mediated through a nuclear vitamin
D receptor (VDR) or by ‘rapid’ membrane initiated pathways via cell-surface receptors.
In recent years it has become evident that a variety of cells and tissues which are not
primarily related to calcium and bone metabolism contain VDR. The role of vitamin D
on other tissues, such as muscle, lung and liver, cardiovascular and reproductive tissues,
has been studied to varying extents. However, further research is needed to specify the
actions of vitamin D metabolites in other tissues (Reichel et al 1989, De Luca and
Zierhold 1998).
18
Figure 2.2. Schematic presentation of vitamin D metabolism in man.
Dietary sources and recommended intake
At higher latitudes vitamin D stores are produced during summer, and in the winter
vitamin D status depends totally on vitamin D supplied by foods. The main dietary
sources of vitamin D in Finland are fish, fortified margarines and egg yolk to a lesser
extent (Lamberg-Allardt 1984, Mattila 1995). In addition, meat, chicken, inner organs,
dairy products and some wild mushrooms contain small amounts of vitamin D (Table
2.1.).
Depending on the supply of vitamin D fortified food products, there are regional
differences in dietary vitamin D intake. In Finland margarines (7 µg/100 g) as well as fat
free milk and milk with 1% of fat (0.08 µg/100 g) are fortified with vitamin D. Recent
population based study showed that in Finland the mean dietary vitamin D intake of
adult men (5.2 µg/d, 25-64 yr) fulfilled the recommendations (5 µg/d, 200 IU, National
Nutrition Council 1998, Table 2.2.), but that of females (3.7 µg/d, 25-64 yr) was below
the recommended intake (The Findiet 1997 Study Group 1998). Fish together with
fortified margarines supply 70-80% of daily vitamin D intake in Finland (Lamberg-
Allardt 1984, Mattila 1995).
     Diet   Liver   Kidneys Main targets
  D2 (plant)
  D3 (animal) 25OHD 1,25(OH)2D    intestine
    ➧ ➧    ➧     bone
     UV-light 24,25(OH)2D
  D3 (vertebrates) and other metabolites
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Table 2.1. Vitamin D contents of food products (Rastas et al 19931, Mattila 19952) .
D3 µg/100 g D2 µg/100 g
Fish
   Rainbow trout
   Salmon
   Perch
   Baltic herring
   Tuna, canned, in water
9.01 , 7.32
131
8.52
9.2 1, 172
2.91
Mushrooms
   Cantharellus tubaeformis
   Cantharellus cibarius
   Wild mushrooms (mixed)
   Cultivated mushrooms
302
132
5.52
0.22
Margarines, fortified 7.01
Milk (skimmed, 1% fat) 0.081
Broiler chicken (with skin) 1.71
Egg 1.41
Liver 0.61
Pork/Beef 0.4-0.71
Table 2.2. Recommended daily dietary vitamin D intake in Finland (National Nutrition Council 1998).
Children Adolescents/Adults
<3 yr
4-10 yr
10 µg
5 µg
11-60 yr
>61 yr
Pregnant/lactating
5 µg
10 µg
10 µg
Bioavailability of vitamin D
The absorption of vitamin D from foodstuffs has been studied in animals, but the
bioavailability of vitamin D in humans has so far been evaluated only from
supplements. Generally, the absorption of vitamin D supplements in humans varies
between 60-90%, but it has been suggested that absorption of vitamin D from natural
sources is lower (Whyte et al 1979, van den Berg 1993, van den Berg 1997).
Interestingly, vitamin D3 has been shown to increase serum vitamin D concentration
more efficiently than vitamin D2 (Trang et al 1998). A single oral dose of radiolabelled
vitamin D (Thompson et al 1966, Sitrin and Bengoa 1987) or relatively high dose of
vitamin D supplement (Barragry et al 1978) has been applied for clinical studies, for
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example when discriminating vitamin D absorbers from malabsorbers. In classical
bioassays mainly rats and chickens were used as test animals when determining the
bioavailability of vitamin D. Generally, in a bioassay, animals in different test groups
are fed different doses of vitamin D, and the vitamin D activity in the foods is
determined by measuring the biological responses seen in bone structures in the test
groups (for example radiographical bone measurement, calcium content or ash content
in bones, Miller and Norman 1984). The main problem in human vitamin D
bioavailability studies is that the amount of vitamin D is relatively low in food products
and serum response cannot be measured. Also, in addition to vitamin D2 and vitamin
D3, other metabolites of vitamin D could contribute to the total vitamin D activity of the
foodstuff. Thus, these bioassays are not applicable in humans when studying the
bioavailability of vitamin D from natural foods (van den Berg 1997). 25OHD is the
main metabolite of vitamin D in the circulation and other vitamin D metabolites cannot
be considered to be important markers of vitamin D status. Consequently, in human
vitamin D bioavailability studies changes seen in serum 25OHD concentration could be
used as a measure of bioavailability.
Vitamin D status
Seasonal variation, normal ranges and vitamin D toxicity
Serum 25OHD concentration is strongly related to sunlight exposure as well as dietary
and supplemental vitamin D intakes. At latitudes around 40 degrees north (or south) and
higher serum 25OHD concentrations are known to vary significantly with seasons,
higher levels have been observed in the summer and lower levels in the winter both in
young and elderly people (MacLaughlin et al 1974, Stamp and Round 1974, Lawson et
al 1979, Omdahl et al 1982, Tjellesen and Christiansen 1983, Lamberg-Allardt 1984,
Lamberg-Allardt et al 1984, Webb et al 1988, McKenna 1992, van der Wielen et al
1995). Beside latitude and season, vitamin D synthesis depends also on other factors,
such as the use of sunscreen and clothes and the amount of melanin in the skin (Holick
et al 1981, MacLaughlin and Holick 1985, Matsuoka et al 1987, Holick 1994). Vitamin
D is predominantly stored in adipose tissue and it has been suggested that the seasonal
variation is greater in lean than in obese subjects (Need et al 1993).
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The reference range for serum 25OHD concentration in humans is generally set at 25-
120 nmol/l. The reference ranges have been obtained from population-based studies
investigating the 25OHD status in healthy adult population. Based on these
measurements and using 95% confidence intervals of the mean, subjects having serum
25OHD concentration below 25 nmol/l are generally defined as vitamin D deficient (for
example see Burnand et al 1992). In vitamin D intoxication concentrations of 1000
nmol/l or greater have been reported (Heaney et al 1997, Vieth 1999). In vitamin D
intoxicity serum 25OHD concentration increases significantly, whereas that of
1,25(OH)2D remains unchanged (Hughes et al 1976). Also, hypercalcemia,
hypercalciuria and calcification of soft tissues have been reported (Vieth 1990). In
adults intoxicity symptoms have been found at high dose levels (1.25 mg Hathcock
1985), but hypercalciuria is also seen when serum 25OHD concentration is higher than
220 nmol/l (Gertner and Domenech 1977, Rizzoli et al 1994). Vitamin D3 causes
intoxicity more often than vitamin D2 (Trang et al 1998). Oral intake of 25OHD has
been found to be 10 times as effective in increasing serum 25OHD levels as compared
to vitamin D (Stamp et al 1977). However, 25OHD is a less potent agent of vitamin D
intoxication than 1,25(OH)2D (Frasier 1995). In vitamin D excess 7-dehydrocholesterol
is metabolised to inactive metabolites, such as tachysterol or lumisterol, and thus
intoxicity has never been reported even after prolonged exposure to sunlight (Haddad
and Chuy 1971). Interestingly, in postmenopausal women vitamin D3 supplementation
(7.5 µg/d) increased low density lipoprotein (LDL) cholesterol concentration in a
supplemented group as compared to controls suggesting that vitamin D supplementation
may have unfavourable effects on lipids (Heikkinen et al 1997). Also, 1,25(OH)2D3 has
been found to cause aggregation (at the levels of 0.01 µg/µl) of both rat and human
platelets in vitro (Awgu and Holub 1983).
The effects of physiological variables, background variables and lifestyle factors on
vitamin D status
In general, the elderly have lower serum vitamin D concentrations than younger adults
(Lund and Sorensen 1979, Omdahl et al 1982, Dattani et al 1984, Lamberg-Allardt
1984, Aksnes et al 1988) which seems to be primarily due to a lower dietary vitamin D
intake and less efficient skin synthesis rather than to an age-related decrease in vitamin
D absorption (Barragry et al 1978, Savolainen et al 1980, Clemens et al 1986, Holick
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1986, Holick et al 1989, Horst et al 1990, Chapuy et al 1996). In addition, older people
have declined renal function and mass, and therefore the production of active
1,25(OH)2D is decreased (Francis et al 1984, St John et al 1992). In some studies serum
25OHD concentrations have been reported to be lower both in young and elderly women
than in men (Sherman et al 1990, van der Wielen et al 1995, Dawson-Hughes et al 1997,
Jacques et al 1997), whereas others have not reported any differences between genders
(Löwik et al 1990, Burnand et al 1992). Serum 25OHD levels have been found to
inversely associate with obesity (Bell et al 1985, Burnand et al 1992, Dawson-Hughes et
al 1997, Jacques et al 1997), but the association has not been found in all studies
(Scragg et al 1992). It has been proposed that lower 25OHD concentrations found in
obese subjects could be due to a higher uptake of vitamin D by adipose tissue or
increased metabolic clearance of vitamin D (Liel et al 1988). Outdoor exercise and UV-
radiation exposure help to maintain an adequate vitamin D status, and the importance of
exercise for maintaining bone turnover in balance have been reported in children (Baer
et al 1997), in adults (Olivieri et al 1999) and in the elderly (Theiler et al 1999). In
female adults (Sowers et al 1986) and in postmenopausal women (Brot et al 1999a)
serum 25OHD levels have been found to be inversely associated with smoking. In the
elderly mild alcohol consumption has been found to positively correlate with 25OHD
concentration (Jacques et al 1997). However, the associations between 25OHD
concentration and smoking or alcohol consumption could be at least partly explained by
other lifestyle factors, such as outdoor exercise and dietary habits. Lower serum 25OHD
concentrations have been found in alcoholics (Laitinen et al 1990), in pregnant and
lactating women (for a review see Specker 1994) and in vegetarians (Millet et al 1989,
Lamberg-Allardt et al 1993). Certain medications, such as anticonvulsants, lower serum
25OHD concentration (Mosekilde et al 1977). It seems that in addition to differences in
dietary intake and sunlight exposure between various groups, vitamin D metabolism in
kidney and liver may be deranged in some groups such as alcoholics or subjects
receiving medication.
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Risk groups studied in Finland
In Finland small children and institutionalised elderly are at risk of having low vitamin
D status (Lamberg-Allardt 1984, Lamberg-Allardt et al 1984, Lamberg-Allardt et al
1986, Honkanen et al 1990). The main reasons for a low vitamin D status in children
and the elderly are decreased dietary vitamin D intake and limited sunlight exposure.
Also, among the elderly intestinal vitamin D absorption and renal 1,25(OH)2D
production may be decreased. Vegetarians who avoid fish, meat and eggs have been
shown to have inadequate dietary vitamin D intake and lower serum 25OHD levels than
omnivores in the winter (Lamberg-Allardt et al 1993, Outila et al 1998). In addition,
decreased mean serum 25OHD concentrations have been found during winter in
children, adolescents and adults (Savolainen et al 1980, Parviainen and Koskinen 1983,
Ala-Houhala et al 1984, Lamberg-Allardt et al 1986, Lehtonen-Veromaa et al 1999).
Bone
Bone turnover
Bone is a connective tissue containing collageneous matrix, mostly type I collagen, and
minerals, mostly in the form of hydroxyapatites. Generally, cortical bone, which is
denser and lesser active bone, surrounds trabecular bone. The adult skeleton consist of
80% of cortical bone, but some sites, for example the lumbar spine, mainly consist of
trabecular bone (Martin et al 1988). Bone remodelling is a continuous process of
resorption, carried out by osteoclasts, and formation, carried out by osteoblasts. In bone
remodelling osteoclasts first resorb old bone. New bone matrix is synthesised by
osteoblasts. Then bone matrix is mineralised and the osteoblasts surrounded by
mineralised matrix are called osteocytes (Parfitt et al 1996). When bone resorption and
formation are equal, bone turnover is in balance. Generally, bone mass decreases with
increased age (Riggs et al 1982), but in osteoporosis bone resorption is increased as
compared to its formation and as a consequence BMD is decreased (Eastell et al 1993,
Kushida et al 1995). 1,25(OH)2D and PTH are the main hormones regulating bone
turnover, but also other hormones and factors, such as calcitonin, insulin, thyroid
hormones, sex and gastrointestinal hormones  affect bone turnover (Canalis 1993,
Kawane et al 1997, Winding et al 1997, Woitge et al 1998).
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Bone growth in adolescence
Peak bone mass is largely (more than 90%) achieved by the end of the second decade
(Bonjour et al 1991, Theintz et al 1992). It has been suggested that genetic factors
account up to 80% of the peak skeletal mass (Matkovic et al 1994, Johnston and
Slemenda 1995, Teegarden et al 1995). Also hormonal, medical and lifestyle factors
determine peak bone mass (Backrach 1993, Seeman 1994). It has been suggested that
body weight and exercise during adolescence are stronger determinants of female BMD
than diet (Felihy et al 1992, Uusi-Rasi et al 1997). In adolescence elevated serum
1,25(OH)2D levels have been found during growth spurts (Chesney et al 1980, Lund et
al 1980, Aksnes and Aarskog 1982) suggesting that increased concentrations of growth
hormone raise 1,25(OH)2D production. 1,25(OH)2D, in turn, increases the intestinal
absorption of calcium and a significant positive correlation between serum 1,25(OH)2D
and bone mass accumulation has been reported in pubertal girls (Ilich et al 1997). In
addition, in a 14-year follow-up study dietary vitamin D intake was positively associated
with peak bone mass in adolescent females (Felihy et al 1992). Boot et al (1997) found
that in normal adolescents, girls with earlier menarche or regular menses had higher
bone mass than those with later menarche or irregular menses. Also, estradiol has been
found to be an important determinant of bone mineral gain in pubertal girls (Blumsohn
et al 1994, Cadogan et al 1998), and in males pubertal growth spurts with an increase in
testosterone concentration has been shown to associate with skeletal growth and
mineralisation (Krabbe et al 1979, Krabbe et al 1982). Thus, several factors affect the
growing skeleton. Fassler and Bonjour (1995) concluded that adolescents that have not
reached optimal peak bone mass are at the risk of developing osteoporosis and fractures
later in life.
Assessment of bone mineral density
Dual energy x-ray absorptiometry (DEXA, or single energy x-ray absorptiometry, SXA)
with low radiation exposure and high precision and accuracy (Mazess et al 1990) is one
of the most frequently used technique for measuring bone mineral content (BMC) and
BMD. DEXA measurements can be made for different measurement sites, such as the
lumbar spine, femoral neck, calcaneus or forearm. The precision for BMD
measurements varies from 0.5 to 2% depending on the measurement site (Sievänen et al
1996). Radiation free quantitative ultrasound (QUS) measures parameters (such as SOS,
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speed of sound, and BUA, broadband ultrasound attenuation) that estimate BMD in
measurement sites, which is often calcaneus in humans. Beside BMD, the ultrasound
technique seems to provide additional information about bone structure and elasticity
(Bouxsein and Radloff 1997, Njeh et al 1997). However, when detecting the effect of
treatment in osteoporotic women, calcaneal ultrasound responses have not been found to
be as good as responses in DEXA measurement of the lumbar spine and femoral neck
(Rosenthall et al 1999). In children aged 11-16 years the ultrasound technique has not
been found to correlate with DEXA (Sundberg et al 1998). However, there is also
evidence that ultrasound combined with DEXA could improve fracture prediction (Njeh
et al 1997). Some other techniques, such as quantitative computer tomography (QCT)
and radiography, have also been used for BMD measurements, but these techniques are
not currently in common use (Cheng et al 1996).
Seasonal variation in bone mineral density
Seasonal variation in bone density with highest spring-summer values has been reported
by Aitken et al (1973) in menopausal women (in May-July 7.5% higher than in
November-December), by Krolner (1983) in adult women (in July-September 1.7%
higher than in January-March) and by Hyldstrup et al (1986) in adult men (in May 2.5%
higher than in January). Overgaard et al (1988) did not, however, find any seasonal
variation in the forearm BMC of adult women, but lumbar spine BMD had the highest
value in winter (approximately 4% higher in January than in July, estimated from the
Figure presented in their article). Similarly, Vanderschueren et al (1991) found seasonal
variation with an increase in the winter (December-May) and a decrease in the summer
(May-October, difference between highest and lowest seasonal mean 1.8%) in lumbar
spine density of healthy young subjects. However, Dawson-Hughes et al (1991) found
that in postmenopausal women lumbar spine BMD decreased from winter to summer
(difference from December to June 1.4%) and increased from summer to winter
(difference from June to December 1.2%). Also Rosen et al (1994) found lower lumbar
spine and femoral neck values from autumn to winter (difference from August to
February 3.6% in the lumbar spine and 3.0% in the femoral neck, respectively) in
elderly women. Hip fracture rates have been found to be highest in the winter (Jacobsen
et al 1990) and greatest with increased latitude (Cumming et al 1995). The fractional
calcium absorption, urinary calcium and phosphate excretions have been shown to be
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related to seasonal variation in serum 25OHD concentration in young women even
when no effects on bone turnover have been found (Zittermann et al 1998).
The effect of lifestyle factors on bone mineral density
The effect of diet on bone
The main nutrients affecting bone metabolism are calcium, vitamin D, phosphate,
sodium and potassium. All these nutrients are needed for bone growth and the
mineralisation process, but calcium is a threshold nutrient. Several studies have shown
that an adequate intake of calcium contributes to the development of peak bone mass
(Johnston et al 1992, Lloyd et al 1993). Also, increased calcium intake reduces bone
loss in postmenopausal women (Dawson-Hughes 1998). Vitamin D increases intestinal
calcium and phosphate absorption and thus is necessary for calcium homeostasis
(Nordin and Morris 1992). High sodium and protein intakes increase calcium excretion
(Nordin et al 1993, Feskanich et al 1996). Also fibre, phytate, oxalate and caffeine may
have negative effects on calcium absorption and bone metabolism (Heaney 1993).
The effect of a vegetarian diet on bone metabolism has been investigated in several
studies over the last few decades. Already in 1968 Wachman and Bernstein (1968)
theorised that a lacto-ovo-vegetarian diet maintains positive calcium balance and thus is
protective to bone health. Later it has been suggested that certain nutrients that are
abundant in a vegetarian diet, such as zinc, magnesium, potassium, fibre and  vitamin C,
positively associated with BMD in premenopausal women (New et al 1997). Tucker et
al (1999) concluded that in elderly women and men fruits and vegetables together with
other alkaline producing components, such as potassium and magnesium, contribute to
the maintenance of BMD. Excessive dietary protein from animal diets, like fish and
meat, with their potential acid load has been suggested to adversely affect bone unless
buffered by the consumption of plant diets with alkaline foods, such as fruits and
vegetables (Barzel and Massey 1998). In contrast, Munger et al (1999) reported that
dietary protein, especially from animal sources, may be associated with a reduced
incidence of hip fractures in postmenopausal women. Heaney (1998, 2001) has
reviewed that excess protein will not harm the skeleton if calcium intake is adequate.
Lloyd et al  (1991) found slightly lower lumbar spine BMD in premenopausal  lacto-
ovo-vegetarians as compared with omnivores, and Chiu et al (1997) and Lau et al
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(1998) reported lower BMD in postmenopausal long-term vegetarians than in
omnivores. Barr et al (1998) found that premenopausal vegetarians tended to have lower
lumbar spine BMD than omnivores suggesting that diet together with low body weight
or low body fat is a risk for low BMD. Also, as compared to omnivores, significantly
lower BMCs have been found in Dutch adolescents that had been on macrobiotic
(vegan-type) diet (Parsons et al 1997). Surprisingly, some studies have suggested that
vegetarians have an average higher BMC than omnivores (Ellis et al 1972, Marsh et al
1980, Marsh et al 1983), others have not reported any differences (Marsh et al 1988,
Tylavsky and Anderson 1988, Hunt et al 1989,Tesar et al 1992). Generally, when
analysing the effect of diet on calcium and bone metabolism of vegetarians (especially
dietary vitamin D, calcium and protein intakes), it is important to categorise vegetarian
diets into appropriate classes. Strict vegans avoid all meat, fish, egg and milk products,
lacto-vegetarians avoid meat, fish and egg products, and lacto-ovo-vegetarians avoid
meat and fish products.
The effects of smoking, alcohol consumption and exercise on bone
Smoking has been shown to increase bone loss in elderly women and men (Burger et al
1998, Krall and Dawson-Hughes 1999), and it has been found to be a significant risk
factor for hip fractures in elderly women (Cummings et al 1995). However, some
studies among adult women and men (Hemenway et al 1988, Daniel et al 1992,
Hemenway et al 1994) and among postmenopausal women (Johnell et al 1995) have not
found any association between smoking and BMD or fracture rate. In middle-aged
women alcohol consumption has been shown to increase the risk for fractures
(Hemenway et al 1988, Hernandez-Avila et al 1991). No association, however, has been
found between alcohol intake and fracture rate in 40-75 year old men (Hemenway et al
1994). Chronic alcoholics have been shown to have high PTH concentrations (Johnell et
al 1982, Bikle 1988). However, acute alcohol intake has been shown to reduce PTH
secretion in adult males (Laitinen et al 1992), whereas three weeks moderate alcohol
consumption raised serum PTH levels (Laitinen et al 1991a). In some studies moderate
alcohol consumption has been shown to increase bone mineral density (Angus et al
1988, Laitinen et al 1991b). Excessive drinking, however, has been found to have
negative effects on bone metabolism (Laitinen et al 1990, Laitinen and Välimäki 1991).
A positive effect of exercise on growing and mature skeletons has been found in several
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studies (Heinonen et al 1996, Haapasalo et al 1998), and especially during puberty
increased exercise has been found to positively affect peak bone mass accumulation
(Välimäki et al 1994, Vuori 1996). For example, higher total body, lumbar spine and
femoral neck BMDs have been found in pubertal females with increased high-impact
exercise (Morris et al 1997). Also, premenopausal females with high-impact loading and
rapid movements have been found to have higher lumbar spine and femoral neck BMDs
than controls (Heinonen et al 1993, Fehling et al 1995).
Vitamin D, calcium and bone metabolism
Vitamin D was originally discovered as an antirachtic factor, thus the effects of vitamin
D on bone metabolism are of particular interest. 1,25(OH)2D regulates osteoblastic
differentiation and function, and it is also involved in the synthesis of collagen, alkaline
phosphatase and osteocalcin in osteoblasts (Franceschni et al 1988, Colvard et al 1989).
1,25(OH)2D is able to stimulate bone resorption by activating osteoclasts, but only
osteoblasts have VDR which respond to 1,25(OH)2D (Merke et al 1986, Colvard et al
1989).
PTH increases the amount and activity of osteoclasts, and thus accelerates bone
resorption (Bingham et al 1969). As only osteoblasts have receptors for PTH, and
osteoclasts do not, it has been suggested that the resorption process is mediated through
osteoblasts (Silve et al 1982, McSheely and Bibby 1985). In fact, recent cell biological
studies, reviewed by Teitelbaum (2000), have shown that PTH and 1,25(OH)2D exert
their osteoclastogenic effects through enhancing the expression of RANKL (receptor for
activation of the nuclear factor kappa ligand) in osteoblasts or in stromal cells, which
promotes osteoclastogenesis and osteoclastic bone resorption.
PTH together with 1,25(OH)2D maintains serum calcium homeostasis by increasing
bone resorption, calcium reabsorption and phosphate excretion in the kidneys, and
intestinal calcium and phosphate absorptions (Figure 2.3.). Reduced serum calcium
concentration  leads to the elevated secretion of PTH (Garabedian et al 1972), which
stimulates the production of 1,25(OH)2D. Elevated serum phosphate concentration
could also increase PTH secretion independently of serum calcium (Fine et al 1993).
The production of PTH is inhibited by increased serum calcium concentration (Herfarth
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et al 1992a). Serum 25OHD may regulate PTH secretion independently of serum
calcium (Khaw et al 1994). In addition, 1,25(OH)2D independently inhibits the
transcription of the PTH gene (Holick 1994).
adequate vitamin D status:
⇒ ⇒ 
                            
_____________________________________________________
vitamin D deficiency:
          ⇒       ⇒       ⇒
→
                                   
Figure 2.3. The regulation of serum calcium (S-Ca) and serum phosphate (S-P)  metabolisms in ‘adequate
vitamin D status’ and in ‘vitamin D deficiency’. In adequate vitamin D status hypocalcemia leads to the
elevated secretion of PTH, which in turn increases the synthesis of 1,25(OH)2D. These physiological
changes lead to normalisation of S-Ca concentration. In vitamin D deficiency low serum 25OHD (S-
25OHD) concentration leads to the decreased intestinal absorption of calcium and phosphate. As a
consequence, S-Ca and S-P concentrations are decreased and the secretion of PTH is increased. Elevated
serum PTH (S-PTH) concentration leads to bone resorption and increased urinary phosphate (U-P)
excretion (U-Ca=urinary calcium, adapted from Kurokawa 1996).
S-Ca ↓  (or S-P ↑) S-PTH ↑ S-1,25(OH)2D ↑
Intestine
Ca and P
absorption ↑
Bone
S-Ca and
S-P ↑
Kidney
U-Ca ↓ and
U-P ↑
S-25OHD ↓ S-1,25(OH)2D ↓ Ca and P
absorption ↓
S-Ca and S-P ↓
S-PTH ↑
Kidney
U-Ca ↓ and
U-P ↑
Bone
S-Ca and
S-P ↑
30
Low vitamin D status and serum parathyroid hormone concentrations
Generally, a subject with reduced vitamin D status is defined as vitamin D insufficient,
and a subject with vitamin D status below the reference range as vitamin D deficient
(Chapuy et al 1997). The physiological consequences reported in vitamin D deficiency
are disturbances in calcium and bone metabolism, impaired muscle function as well as
muscle weakness and pain. The main determinants of vitamin D deficiency are sunlight
deprivation, low dietary and supplemental vitamin D intakes, physiological and medical
causes, such as renal insufficiency or vitamin D malabsorption (Chapuy and Meunier
1997). The production of 1,25(OH)2D is generally tightly regulated, and in vitamin D
deficiency the production of 1,25(OH)2D is substrate dependent (Bouillon et al 1987,
Lips et al 1988, Ooms et al 1995a). In severe vitamin D deficiency serum 1,25(OH)2D
concentrations are decreased, but in mild vitamin D deficiency 1,25(OH)2D
concentrations remain unchanged (Peacock et al 1985, Bouillon et al 1987, Chapuy and
Meunier 1997). Additionally, when studying the effects of low vitamin D status on the
metabolism of calciotropic hormones, circadian rhythms in the serum concentrations of
PTH (Herfarth et al 1992b) and 1,25(OH)2D (Rejnmark et al 2000) should be taken into
account.
In prolonged nutritional vitamin D deficiency the secretion of PTH is increased and
secondary hyperparathyroidism developed. An inverse association between serum
25OHD and PTH concentrations have been reported in the elderly (Krall et al 1989,
Gloth et al 1995, Ooms et al 1995a, Chapuy et al 1997), in adults (Lukert et al 1987,
Lukert et al 1992, Landin-Wilhelmsen et al 1995) and in adolescents (Guillemant et al
1995) as well as in children (Olivieri et al 1993). However, several studies have reported
an increase in serum PTH with age (Gallagher et al 1980, Marcus et al 1984, Epstein et
al 1986), and it has been suggested that secondary hyperparathyroidism in the elderly is
the result of both vitamin D deficiency and renal insufficiency (Freaney et al 1993), or
due to an age-related decrease in calcium absorption (Cannigia et al 1963, Bullamore et
al 1970, Alevizaki et al 1973). Others have concluded that in the elderly the increase in
serum PTH concentrations are explained more by vitamin D deficiency than declined
renal function (Flicker et al 1992, Gallagher et al 1998). In an adult population serum
PTH has been found to increase markedly with BMI (Landin-Wilhelmsen et al 1995),
but no significant differences in PTH concentrations between genders have been
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reported (Sherman et al 1990, Landin-Wilhelmsen et al 1995). The metabolism of PTH
has not been studied much among adolescents, but Krabbe et al (1982) reported that on
average serum PTH values in children and adolescents exceeded normal adult values.
Cadogan et al (1998) found in pubertal girls that serum PTH levels were reduced
significantly from early to late puberty when evaluated in terms of postmenarche.
Recently, Cioffi et al (2000) found that serum PTH concentration showed an increasing
tendency in 8 to 14 year old females and in 8 to 16 year old males.
The determination of adequate vitamin D status
Based on the serum 25OHD concentration the definition for vitamin D deficiency varies
between studies from 10 to 50 nmol/l (for a review see Chapuy et al 1997), and usually
the reference ranges are set for healthy adults living in various latitudes, not for different
age groups. The differences in the cutoffs and thresholds proposed by different authors
maybe explained due to the variability and differences in 25OHD assays (Jongen et al
1984, Lips et al 1999). Generally, three methods have been used for serum 25OHD
measurements; radioimmunoassay (RIA), competitive protein binding assay (CPBA,
often with preanalytic chromatographic purification) and high-performance liquid
chromatography (HPLC, often with UV-detection). HPLC has a high sensitivity. RIA
has been shown to correlate highly (r=0.84, p<0.01) with HPLC (Lips et al 1999). In
Finnish studies done in 1980’s, serum 25OHD concentration was mainly measured
using CPBA method with preanalytical chromatographic purification (Parviainen et al
1983, Ala-Houhala et al 1984, Lamberg-Allardt et al 1984). Commercial RIA-kits
became available in 1990’s. However, no studies have been published on the
interlaboratory differences regarding the 25OHD measurements in Finland. Thus, also in
Finland interlaboratory variation may distort comparison between different studies.
In 1985 Peacock and colleagues showed that in elderly subjects secondary
hyperparathyroidism and calcium malabsorption occur when serum 25OHD is lower
than 10 nmol/l (Peacock et al 1985). Based on that definition a serum 25OHD
concentration of 10 nmol/l was the cutpoint for vitamin D deficiency. In vitamin D
insufficiency, 25OHD levels range from 10 to 50 nmol/l and mild hyperparathyroidism
with suboptimal calcium absorption can be found (Peacock et al 1985). However, in
most of the studies the definition for low or desirable vitamin D status is based either on
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the changes seen in 1,25(OH)2D concentration in low 25OHD levels or on the
regression analysis between serum 25OHD and PTH concentrations in the study group.
Peacock et al (1985) and Docio et al (1998) reported that at serum 25OHD
concentrations above 50 nmol/l there were no increase in serum 1,25(OH)2D
concentration in the elderly and in children. They suggested that serum 25OHD
concentration of 50 nmol/l should be the limit for the low vitamin D status. In more
recent studies made in young and older populations the definition is based on the
relation of  25OHD to PTH, and serum 25OHD concentrations from 30 to 110 nmol/l
have been suggested to be the thresholds for low vitamin D status. However, a threshold
value from 37 to 40 nmol/l is often presented (Table 2.3.).
It has been suggested that in the absence of sunlight daily dietary vitamin D intake of
10-20 µg is needed to maintain adequate vitamin D status throughout the year in the
elderly (Webb et al 1990, Dawson-Hughes et al 1991, Chapuy et al 1992). However,
others have suggested that in postmenopausal women a daily vitamin D intake of 5.5 µg
is enough to maintain serum 25OHD and PTH levels constant throughout the year (Krall
et al 1989). An adequate intake of dietary calcium reduces PTH secretion both in young
and elderly subjects (Dawson-Hughes et al 1988, Kochersberger et al 1991, Kärkkäinen
et al 1998). Kinuamy et al (1998) showed that the role of vitamin D is more significant
than the role of a calcium intake (100-1700 mg/d) in suppressing secondary
hyperparathyroidism in the elderly.
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Table 2.3. Studies investigating the association between serum 25OHD and PTH concentrations. The
threshold value for low serum 25OHD concentration was the point at which serum PTH concentration was
at its minimum or a plateau was reached.
Study N Age
(yr)
vit-D
intake
(µg/d)
Ca
intake
(mg/d)
Sampling Serum
25OHD
(nmol/l)
Serum
PTH
(ng/l)
Threshold
for low
S-25OHD
Ooms
et al 1995a1
330 F 80 NA NA overnight
fast
28 43 ∼30
Dawson-
Hughes
et al 19971
209 F
182 M
71
71
4.5
5.0
713
752
overnight
fast
69
82
44
42
∼110
Kinuamy
et al 19981
245 F  -
131 F +
71
71
3.5
3.4
704
818
fast 74
88
37
34
∼75
Gloth
et al 19951
116 -
85F, 31M
128 +
47F, 81M
65-96
65-95
NA NA overnight
fast
31
52
47
42
∼37
Need
et al 20002
496 F 62 NA NA overnight
fast
61 48 ∼40
Krall et al
19893
333 F 58 2.6 408 overnight
fast
80 32 ∼95
Chapuy
et al 19971
804 F
765 M
35-60
45-60
2.8
4.0
793
910
fast 60
62
39
40
∼78
Thomas et al
19984
290
152 F
138 M
18-95 7.5 NA overnight
fast
37.5 NA ∼38
Guillemantet
al 19995
175 M 13-17 NA 809 NA 59 (S)
21 (W)
30 (S)
46 (W)
∼83
Docio et al
19986
9 F
12 M
7-10 ∼3 790 NA ∼21
baseline
NA ∼50
NA=not assessed/incomplete data, F=female, M=male, +/-=using/not using vitamin D supplements, or
controls/sunlight-deprived
1threshold determined by using regression analysis between serum 25OHD and PTH concentrations
2subjects categorised into ten classes (in increments of 10 nmol/l) according to their 25OHD
concentration, threshold estimated from graph
3threshold determined by estimating the adequate dietary vitamin D intake to keep 25OHD and PTH
concentrations constant throughout the year
4subjects categorised into seven classes (in increments of 12.5 nmol/l) according to their 25OHD
concentration, threshold estimated from graph
5same subjects measured first in the summer (S), then in the winter (W), all data included into the
regression model when determining the threshold
6group supplemented with 25OHD (40 µg/d), threshold determined by analysing the changes seen in
serum PTH status after supplementation
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Low vitamin D status and bone metabolism
Prolonged vitamin D deficiency leads to secondary hyperparathyroidism which increases
bone turnover and bone loss in the long run. It is well known that vitamin D deficiency
leads to rickets in children and osteomalacia in adults, processes in which the bone
matrix is not normally mineralised (Parfitt et al 1982). A daily vitamin D intake of 2.5
µg/d has been suggested to be needed to avoid osteomalacia (Dent and Smith 1969).
However, in elderly women even mild vitamin D deficiency with elevated PTH
concentration has been shown to have negative effects on bone metabolism (Krall et al
1989, Dawson-Hughes et al 1991). Also, in perimenopausal women an adequate vitamin
D status has been shown to preserve bone mass by reducing serum PTH concentration
(Lukert et al 1992).
Parfitt et al (1982) and Fonseca et al (1988) have shown that especially cortical bone is
more susceptible to bone loss due to vitamin D deficiency and secondary
hyperparathyroidism. Low vitamin D status with elevated PTH levels has been
associated with increased bone turnover and bone loss in postmenopausal women and
the elderly (Lips et al 1983, Krall et al 1989, Dawson-Hughes et al 1991, Villareal et al
1991, Rosen et al 1994, Dawson-Hughes et al 1995, Ooms et al 1995a, Chapuy et al
1996, Collins et al 1998), and in perimenopausal and middle-aged women PTH and
bone density are inversely correlated (Lukert et al 1987, Khaw et al 1992). Vitamin D
deficiency and elevated PTH concentrations have been found in patients with hip
fractures (Aaron et al 1974, Lips et al 1987, Kavookjian et al 1990, Chapuy et al 1994,
Ng et al 1994). In perimenopausal women serum 1,25(OH)2D has been found to be
inversely and 25OHD positively related to bone mass (Brot et al 1999b). Recently,
Kristinsson et al (1998) found that serum 25OHD concentration and forearm distal
BMD correlated positively in 16 year old females. However, no correlation was found
between serum 25OHD concentration and other measured BMD sites (lumbar spine,
hip, total skeleton, Kristinsson et al 1998). Vitamin D deficient London Asian
vegetarians have been found to suffer from secondary hyperparathyroidism (Finch et al
1992). Finnish vegans have been found to suffer from vitamin D deficiency and
secondary hyperparathyroidism in the winter (Lamberg-Allardt et al 1993).
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Vitamin D supplementation, calcium and bone metabolism
Vitamin D supplementation increases 1,25(OH)2D production and suppresses PTH
secretion in elderly suffering from vitamin D deficiency (Lips et al 1988, Ooms et al
1995b). In several studies vitamin D and calcium supplementation have been found to
increase bone mass and decrease fracture rate in elderly women and men (Chapuy et al
1987, Dawson-Hughes et al 1990, Dawson-Hughes et al 1991, Chapuy et al 1992,
Chapuy et al 1994, Chapuy and Meunier 1996, McKane et al 1996, Dawson-Hughes et
al 1997). A single oral cholecalciferol dose (2.5 mg) suppressed the increase in PTH
secretion in older men and women during winter (Khaw et al 1994), and annual
intramuscular ergocalciferol injection (3.75-7.5 mg) decreased fracture incidence in
elderly females but not in elderly males (Heikinheimo et al 1992). Krall et al (1989) and
Dawson-Hughes et al (1991) reported that in postmenopausal women the increase in
vitamin D intake prevents both the rise in serum PTH and decrease in BMD. Two years
vitamin D treatment (5 µg/d) for postmenopausal women decreased bone loss in the
spine and whole body but not in the femoral neck (Dawson-Hughes et al 1995). Several
studies have shown that supplementation with 10 µg/d for 2-24 months increases serum
25OHD concentration by ~40 nmol/l in adults and elderly (Davie et al 1982, Lips et al
1988, Ooms et al 1995b, Chel et al 1998). Khaw et al (1992) estimated that 40 nmol/l
increase in serum 25OHD concentration would be associated with a 5-10% increase in
bone density in middle-aged women. Dawson-Hughes (1996) reviewed that at least
postmenopausal women should consume daily 1000-1500 mg of calcium and 10-20 µg
of vitamin D to minimise bone loss. Interestingly, short term cholecalciferol
supplementation has been shown to increase PTH secretion in young (van der Klis et al
1996) and in elderly women (Lips et al 1988). Also, in vitamin D deficient Asian
vegetarians the persistence of increased PTH secretion has been reported after one year
vitamin D supplementation (Dandona et al 1984).
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3. Aims of the study
The vitamin D status of people is changing from high concentrations in the summer to
low concentrations in the winter in Finland. Earlier studies have shown that especially
small children and elderly people are at the risk for a decreased serum vitamin D
concentrations in the winter, but vitamin D status of adolescents and young adults has
not been well investigated in population based studies. Among the elderly it has been
reported that the secretion of PTH is elevated in vitamin D deficiency which has been
shown to have several adverse effects on bone metabolism. However, there have been
only a few studies investigating the effect of mild vitamin D deficiency on calcium and
bone metabolism among adolescents and young adults. Finnish vegetarians have been
shown to suffer from low vitamin D status during winter, but the effects of low vitamin
D status and vitamin D supplementation on bone metabolism of vegetarians have not
been evaluated. Edible mushrooms could be an important dietary vitamin D sources for
vegetarians, but the bioavailability of vitamin D from mushrooms in humans is
unknown. A method for measuring the bioavailability of vitamin D from foodstuffs has
to be developed.
The aims of the study were:
1. To determine the vitamin D status of  Finnish adolescents (14-16 yr) and adults (31-
43 yr) during winter, and to evaluate the effect of vitamin D status on calcium and bone
metabolism in the study groups (studies I and II).
2. To study vitamin D status, calcium and bone metabolism of vegetarians (both vegans
and lacto-vegetarians) during one year (study III).
3. To investigate the effect of 11 months of ergocalciferol supplementation on calcium
and bone metabolism of vegetarians (study IV).
4. To assess the bioavailability of ergocalciferol from wild edible mushrooms
(Cantharellus tubaeformis) in healthy adults by developing new human bioassay (study
V).
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4. Subjects and methods
Study designs
In studies I and II vitamin D, calcium and bone metabolism of Finnish adolescents and
adults were investigated in population based samples. Fasting blood samples, BMD
measurements and background information were collected in February-March 1997 and
February-March 1998, respectively.
In study III vitamin D status and bone metabolism of premenopausal vegetarians and
omnivores during one year was evaluated. Background information, fasting blood
samples and 24 hour urinary samples were collected, BMD was measured, and the
strontium absorption test was carried out in February 1994, August 1994 and January
1995.
In study IV the effect of 11 months of ergocalciferol supplementation (5 µg/d) on
calcium and bone metabolism of vegetarians was evaluated. In study IV fasting blood
samples, 24 hour urinary samples, BMD measurements and background information
collection was made in the beginning (April 1995) and at the end of the study (February
1996).
In study V the bioavailability of vitamin D from wild edible mushrooms was
investigated during three weeks in January-February 1996. The mushrooms were
obtained during the autumn 1995 from a local retail store. The subjects were randomly
divided into three groups. Group one received pooled, lyophilised and homogenised
mushrooms (Cantharellus tubaeformis), group two ergocalciferol supplement and group
three no supplementation. Serum and urinary samples as well as background
information were collected at the beginning, in the middle and at the end of the study.
In all studies serum samples were stored at -20°C until analysed. In studies III and V
subjects were asked to maintain their habitual diets and not to eat vitamin D containing
foods and supplements or travel to sunny places during the study period. However, due
to a long study period, in study IV the omnivores were allowed to use vitamin D
supplements or to travel to sunny areas if they wanted.
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Subjects
The subjects (n=231, 14-16 year old adolescents) for study I were recruited from upper
levels of comprehensive schools in the capital area (Helsinki-Kerava-Porvoo). Study II
was organised in Helsinki-Vantaa and Turku-Loimaa areas and invited subjects (n=328,
31-43 year old adults) had participated in ‘The National Finrisk Study’ performed by the
National Public Health Institute in the spring 1997 in which participants were randomly
invited (The Findiet 1997 Study Group 1998).
Premenopausal healthy female vegetarians (6 vegans and 6 lacto-vegetarians) and
omnivores (16) participated for the vegetarian study (study III) conducted from February
1994 to January 1995 in Helsinki. Participants for study III were recruited through
advertising at vegetarian restaurants, health food stores, through a local vegetarian
society and at the University of Helsinki. Of these subjects 5 vegans, 5 lacto-vegetarians
and 10 omnivores volunteered for the ergocalciferol supplementation study (study IV)
from April 1995 to February 1996. 27 premenopausal healthy females from the
University of Helsinki participated for the vitamin D bioavailability study (study V,
Table 4.1.).
Table 4.1. Background characteristics of the study groups (mean+SD).
Study N Age
(yr)
Weight
(kg)
Height
(cm)
BMI
(kg/m2)
I 178 females
53 males
15+1
15+1
55+8
 62+10
165+6
174+9
20+2
20+2
II 202 females
126 males
38+3
37+4
 66+12
 83+12
166+7
179+6
24+4
26+4
III* 6 vegans
6 lacto-veg.
16 omnivores
37+7
33+9
33+7
57+9
58+7
 63+10
167+6
167+6
166+6
20+3
21+2
23+4
IV* 5 vegans
5 lacto-veg.
10 omnivores
38+8
 32+10
34+7
 60+11
58+7
 65+13
169+3
166+6
166+5
21+3
21+2
23+5
V* 9 (group 1)
9 (group 2)
9 (group 3)
25+6
 29+11
29+8
57+8
60+6
65+6
166+8
164+6
169+6
20+1
23+3
23+3
*all subjects females
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Methods
Laboratory measurements
Serum 25-hydroxyvitamin D and intact parathyroid hormone (iPTH) concentrations
were analysed by the methods presented in Table 4.2. In competitive protein binding
assay (CPBA, studies III-V) serum was first extracted with acetonitrile and the
metabolites were purified chromatographically using SepPak cartridges (Amersham
International, UK) and hexane/isopropanol for elution. The 25OHD concentration was
determined by saturation analysis in which 3H-labelled 25OHD was used as a tracer and
human serum as a source of binding protein. The radioimmunoassay (RIA, studies I-II)
technique uses an antibody against the 25OHD-molecule and a 125I-labelled 25OHD as a
tracer. Serum intact PTH was measured by an immunoradiometric assay (IRMA). In this
method two antibodies are used. First, the ‘capture’ antibody, binds intact PTH
molecules and PTH fragments containing mid-region and/or carboxyterminal portion.
The second, 125I -labelled antibody, binds both ‘captured’ intact PTH and also free
aminoterminal PTH fragments. Before counting, aminoterminal radiolabelled PTH
fragments are washed away. Thus, only intact PTH molecules are counted.
Serum calcium and phosphate (studies I-V, reference range for S-Ca: 2.20-2.70 mmol/l
and for S-P: 0.85-1.40 mmol/l) and urinary calcium and phosphate (studies III-V,
reference range for U-Ca: 1.30-5.50 mmol/24 h urine and for U-P: 20-50 mmol/24 h
urine) concentrations were measured by automated laboratory methods with
colorimetric analyses. In studies III-IV analyses were made with Cobas Mira Chemistry
Analyzer (Roche, Switzerland) in ‘Medix Laboratories Oy’ (Kauniainen, Finland, CV%
for S-Ca and U-Ca: 1.50-1.70%, and for S-P and U-P: 2.20-2.50%, respectively). In
studies I, II and V the analyses were made in the University of Helsinki, Division of
Nutrition with Elan Automatic Analyzer (Eppendorf-Netheler-Hinz GmbH, German,
CV% for S-Ca and U-Ca: 1.20-1.60%, and for S-P:2.90%).
The intestinal absorption of calcium (studies III and V) was estimated using the stable
strontium method of Milsom et al (1987). In brief, 2.5 mmol of stable strontium chloride
was ingested in 200 ml of water with a light breakfast and blood was sampled four hours
later. The strontium concentration was measured by atomic absorption
spectrophotometry at 460.7 nm using a lanthanum chloride/hydrochloric acid diluent as
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a buffer. The fractional calcium absorption was calculated using equation:
(0.15*strontium concentration*weight)/25. The CV % was 1.8 at the level of 20 µmol/l.
Table 4.2. Methods used for the measurement of the concentrations of serum 25OHD and iPTH
in studies I-V.
Parameter Study Method Manufacturer Reference range CV %
(intra)
CV%
(inter)
25OHD I-II RIA Incstar 25-120 nmol/l 10 15
25OHD III-V CPBA In-house method1 25-120 nmol/l 15 14
iPTH I IRMA Incstar 10-55 (ng/l) 3 6
iPTH II-V IRMA Nichols 10-65 (ng/l) 1 4
1Törnquist and Lamberg-Allardt 1987
Measurement of bone mineral density
Forearm BMDs (g/cm2) were measured by portable densitometers with DEXA (Dual
Energy X-ray Absorptiometry) techniques, DTX-200 Osteometer (Osteometer
MediTech A/S, Denmark) in study I and by PIXI densitometer (Lunar Corporation,
Madison, Wisconsin, USA) in study II. In studies III and IV femoral neck and lumbar
spine BMDs were measured with DEXA, Lunar DPX (Lunar Corporation, Madison,
Wisconsin, USA, Table 4.3.). The quality control of measurements were made daily
with phantoms provided by manufacturers.
Table 4.3. Methods used for the measurement of BMD parameters in studies I-IV.
Parameter Study Method Manufacturer CV%
(inter)
Forearm I DEXA Meditech 0.7
Forearm II DEXA Lunar corp. 0.4
Lumbar spine III-IV DEXA Lunar corp. 0.9
Femoral neck III-IV DEXA Lunar corp. 1.2
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Nutrient intakes
In all studies the dietary intakes of vitamin D and calcium were estimated by food
frequency questionnaires (FFQ) including the pictures of portion sizes (Seppänen et al
1993). Around 50 food items containing large amounts of calcium and vitamin D are
included in the FFQ. In studies III-V FFQs were interviewed by a nutritionist, and in
studies I and II subjects filled the questionnaires themselves using the instruction sheet.
However, when the FFQs were returned, a nutritionist checked the FFQs together with
the subject. In study V three dietary records were also collected, and the dietary intake of
nutrients was calculated using the Finnish food composition tables (Rastas et al 1993).
Collection of background information
In studies III-V the background information (age, height, weight, the use of
supplements, smoking habits, alcohol consumption, exercise, medication, allergies,
illnesses, special diets, holidays spent in sunny places abroad) were inquired by
interviews. In studies I and II self-reported questionnaires were used to collect all
background information. Each questionnaire was checked by a nutritionist together with
a subject.
Statistical analyses
The data are expressed as the mean+SD (in text and tables) or the mean+SEM (in
Figures). Logarithmic transformations were used for non-normally distributed data. P-
value <0.05 was considered significant, unless otherwise stated. Statistical analyses
were performed using the BMDP Software (Dixon et al 1988) in the Unix
minicomputer.
In studies III-V the analysis of variance (ANOVA) with repeated measures was used to
analyse the differences in biochemical variables among the study groups and periods.
ANOVA was used to test the differences between study groups (I-V). Post-hoc analyses
were made with t-test or Mann-Whitney U-test. Analysis of covariance (ANCOVA) was
performed when adjustment for other variable was needed. Linear and non-linear
regression analysis were used to study the relationships between variables.
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5. Results
Basic background, dietary and biochemical data of the study groups are presented in
Tables 4.1. and 5.1. Data concerning adolescent males is unpublished.
Table 5.1. Background data of the study groups (mean+SD).
Study N VitD-intake
(µg/d)
Ca-intake
(mg/d)
S-25OHD
(nmol/l)
S-PTH
(ng/l)
Exercise
(min/d)
Height
velocity
(cm/yr)
I 178 females
53 males
4.3+2.8
4.4+3.0
1216+591
1688+751
 39+14
 38+15
30+14
32+13
76+37
103+57
2.3+2.0
7.3+3.0
II 202 females
126 males
4.7+2.5
5.6+3.2
 962+423
1037+489
 47+34
 45+35
30+13
24+12
49+42
34+30
-
-
III* 6 vegans
6 lacto-veg.
16 omnivores
0.1+0.1
0.7+0.4
4.0+2.1
 743+180
1159+462
  808+240
     24+4
 27+11
 48+19
  59+22
40+10
33+13
32+23
26+16
25+20
-
-
-
IV* 5 vegans
5 lacto-veg.
10 omnivores
0.2+0.2
1.0+0.7
3.9+2.0
  721+310
1117+661
  855+179
27+5
 34+20
 39+18
47+14
41+21
27+14
-
-
-
-
-
-
V* 9 (group 1)
9 (group 2)
9 (group 3)
1.2+0.6
1.2+0.6
1.4+0.6
 902+393
 951+300
1326+385
 31+10
31+6
 37+12
51+17
47+20
60+25
-
-
-
-
-
-
S-25OHD=serum 25OHD concentration, S-PTH=serum parathyroid hormone concentration
*all subjects females, in study V only subjects with low dietary vitamin D intake were selected
Serum 25OHD and PTH concentrations in Finnish adolescents during winter
(study I)
The mean serum 25OHD and PTH concentrations did not differ between sexes, and the
mean dietary vitamin D intake almost met the recommendations in both sexes (5 µg/d,
National Nutrition Council 1998, Table 5.1.). A vitamin D deficiency, based on the
reference range and defined as the serum 25OHD concentration equal or lower than 25
nmol/l, was observed in 24 of 178 females (13.5%) and 8 of 53 males (15.1%). Elevated
serum PTH concentration, defined as the serum PTH concentration higher than 55 ng/l,
was observed in 9 of 178 females (5.1%) and 1 of 53 males. To determine the threshold
for low vitamin D status, a non-linear regression model was fitted between serum
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25OHD and PTH concentrations (Figure 5.1.). In the males the plateau for serum PTH
concentration was reached at serum 25OHD concentration ~40nmol/l, which was the
cutpoint for low vitamin D status in the males. In the females the relationship between
25OHD and PTH did not reach a plateau. Thus, the subjects were divided into two
groups depending on the mean PTH value of 30 ng/l. From the equation it can be
calculated that in the adolescent females the mean PTH concentration of 30 ng/l can be
reached at serum 25OHD concentration higher than ~40 nmol/l  [29.6 ng/l=12.1 ng/l +
27.0*exp(-0.011*39.5 nmol/l)]. Similarly, in the whole study group the mean PTH
concentration of 30 ng/l can be reached at serum 25OHD concentration higher than ~40
nmol/l [30.1 ng/l=9.3 ng/l + 31.0*exp(-0.103*39 nmol/l)]. Thus, based on the relation
between serum 25OHD and PTH concentrations, 61.8% of the females and 64.2% of the
males had serum 25OHD concentrations lower than 40 nmol/l (Figure 5.1.). In the
whole study group 144 subjects (62.3%) had serum 25OHD concentration equal or
lower than 40 nmol/l (Figure 5.1.). Vitamin D containing supplements and sunlight
exposure were found to be the stronger determinants of serum 25OHD concentration
than dietary vitamin D intake. In the females sampling time, yearly mean height velocity
and serum 25OHD concentration predicted serum PTH concentration, but in the males
age was found to the strongest determinant of the serum PTH concentration.
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Figure 5.1. The association between serum 25OHD and PTH concentrations in adolescent females (a,
n=178), in adolescent males (b, n=53) and both in females and males (c, n=231).
Serum 25OHD and PTH concentrations in Finnish adults during winter (study II)
The mean dietary vitamin D intake almost met the recommendations in the females and
exceeded the recommendations in the males (5 µg/d, National Nutrition Council 1998,
Table 5.1.). On an average, females had higher serum PTH concentrations than males
(p<0.001), but serum 25OHD levels did not differ between sexes (Table 5.1.).
Proportions of persons having serum 25OHD concentrations lower than 25 nmol/l were
26.2% in the females (53 females) and 28.6% in the males (36 males), respectively.
Serum 25OHD concentrations higher than the reference limit of 120 nmol/l was found
in 15 of 328 subjects (4.6%), 10 of them used regularly vitamin D supplements and 3
had recently been on sunny areas abroad. Elevated serum PTH concentration, defined as
the serum PTH concentration higher than 65 ng/l, was observed only in 1 female and in
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1 male. Serum PTH concentration increased when serum 25OHD concentrations was
lower than ~80 nmol/l in the females and ~40 nmol/l in the males, respectively (Figure
5.2.). The serum 25OHD concentration was lower than 80 nmol/l for 173 (85.6%) of
202 females and lower than 40 nmol/l for 71 (56.3%) of 126 males. Dietary and
supplemental vitamin D intakes were important predictors of vitamin D status. Serum
25OHD accounted inversely for serum PTH status in the females, but in the males
calcium intake was stronger determinant of serum PTH concentration than any other
tested variable.
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Figure 5.2. The association between serum 25OHD and PTH concentrations in adult females (a, n=202)
and males (b, n=126). In graphs c) and d) the association is presented in females (c, n=194) and males (d,
n=119) with serum 25OHD concentration equal or lower than 120 nmol/l.
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The effect of vitamin D status on BMD in adolescents and adults (studies I and II)
The adolescents: Based on the relation between serum 25OHD and PTH concentrations
the effect of low vitamin D and higher PTH concentration on forearm BMD were
studied in both genders. Serum 25OHD concentrations equal or lower than 40 nmol/l
was associated with lower forearm BMD in radius (p=0.04) and tended to be associated
in ulna (p=0.08) in the female adolescents, but serum PTH did not significantly predict
forearm BMD (Table 5.2.).
Table 5.2. Differences in forearm BMD measurements (ulna and radius, mean+SD) in the female
adolescents divided into two categories according to I) serum 25OHD concentration (<40 or >40 nmol/l,
based on the relation between serum 25OHD and PTH concentration) and II) serum PTH concentration
(<30 or >30 ng/l).
                               I
                   serum 25OHD (nmol/l)
<40 (n=110)           >40 (n=68)              p*
                             II
                  serum PTH (ng/l)
<30 (n=108)          >30 (n=70)               p*
ULNA-BMD
(g/cm2)
0.343+0.047 0.351+0.043 0.08 0.348+0.048 0.342+0.042 0.38
RADIUS-BMD
(g/cm2)
0.419+0.054 0.434+0.053 0.04 0.428+0.055 0.420+0.053 0.34
*Mann-Whitney rank sum test
In the male adolescents the effect of low vitamin D status (<40 nmol/l) on forearm
BMD was also evaluated, but probably due to the small sample size and type II error,
the means did not differ significantly (p-values 0.40...0.79).
The adults: The mean values of measured BMD sites did not differ between groups
categorised by low vitamin D status in neither sexes, but significantly lower forearm
BMD were found in the males and tended to be found in the females with elevated
serum PTH concentrations (Table 5.3.).
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Table 5.3. Differences in forearm BMDs (mean+SD) in adult females (a) and males (b) divided into two
categories according to I) S-25OHD concentration (<80 or >80 nmol/l in the females, <40 or >40 nmol/l
in the males, based on the relation between serum 25OHD and PTH concentration) and II) S-PTH
concentration (<26 or >26ng/l in the females, <23 or >23 ng/l in the males).
a) Females
                                I
                    serum 25OHD (nmol/l)
<80 (n=173)           >80 (n=23)             p*
                             II
                  serum PTH (ng/l)
<26 (n=78)            >26 (n=118)             p*
BMD ( g/cm2)
b) Males
 0.435+0.041
<40 (n=71)
 0.437+0.063
>40 (n=53)
0.96
  p*
 0.440+0.044
<23 (n=63)
 0.432+0.044
>23 (n=61)
 0.14
  p*
BMD (g/cm2)  0.531+0.063  0.538+0.066 0.65  0.548+0.065  0.519+0.059  0.01
*Mann-Whitney rank sum test
The determinants of forearm BMD in adolescents and adults (studies I and II)
In the adolescent females a regression analysis including serum 25OHD and serum PTH
concentrations with background variables and lifestyle factors (age, BMI, calcium
intake, exercise, smoking, alcohol consumption) revealed that the strongest determinants
of forearm BMD in these growing adolescent females were BMI (pulna<0.001,
pradius<0.001) and height velocity (pulna<0.001, pradius<0.001) together with daily exercise
rate (pulna=0.14, pradius=0.04). In the females the tested variables explained 37%
(pmodel<0.001) and 34% (pmodel<0.001) of the variance in radius and ulna BMDs,
respectively.
In the male adolescents a regression model with all variables revealed that forearm
BMD was positively associated with BMI (pulna=0.01, pradius<0.001) and age (pulna=0.04,
pradius=0.03), but inversely with height velocity in radius (p=0.02). In the males the
tested variables explained 49% (pmodel<0.001) and 48% (pmodel<0.001) of the variance in
radius and ulna BMDs, respectively.
In the adults age, BMI, height, calcium intake, serum 25OHD and serum PTH
concentrations, smoking frequency, alcohol consumption and daily exercise were used
as independent variables in the regression models. In these regression models the
explanation of the variation in forearm was 15% (pmodel<0.001) in the females and 3%
(pmodel=0.917) in the male adults. One unit increase in BMI significantly increased
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forearm BMD by 0.004 (p=0.005) units in the females, and current smoking decreased it
by 0.015 (p=0.05) units. In the adult males none of the tested variables affected
significantly on forearm BMD.
The effect of low vitamin D status on calcium metabolism and BMD in vegetarians
(study III)
No seasonal variation was found in calcium and vitamin D intakes within the
vegetarians and omnivores during the study. The yearly mean dietary vitamin D intake
was significantly lower in vegans (p<0.05, Table 5.1.) and in lacto-vegetarians (p<0.05)
as compared to the omnivores. Calcium intake did not differ between the groups (Table
5.1.). In the beginning of the study (February 1994) significantly higher serum 25OHD
concentrations were found in omnivores as compared to vegans (p=0.01) and lacto-
vegetarians (p=0.01). However, in the second winter (January 1995) serum 25OHD
concentrations tended to differ only between vegans and omnivores (p=0.15). Both
within vegans and lacto-vegetarians the serum PTH concentrations followed seasons,
being higher in the winter than summer. In the summer the serum PTH concentrations
did not differ between the groups (p=0.41, Figure 5.3.). The intestinal absorption of
strontium, which reflects calcium absorption, was highest in vegans and showed in all
groups a seasonal variation with higher summer values (p=0.03). The urinary calcium
excretion remained higher in omnivores than in lacto-vegetarians and in vegans
throughout the year (p=0.03).
No seasonal variation was found in BMD (adjusted for age and BMI) in the study
groups. Lumbar spine BMD was lower in vegans than in omnivores (p=0.05) and tended
to be lower than in lacto-vegetarians (p=0.17). Femoral neck BMD tended to be lower in
vegans than in omnivores (p=0.07) and in lacto-vegetarians (p=0.15, Figure 5.3.).
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Figure 5.3.
a) Seasonal changes in serum PTH concentration (ng/l, mean+SEM, upper panel) and serum 25(OH)D
concentration (nmol/l, lower panel) among the groups during the study. Compared to lacto-vegetarians
( =lacto-vegetarians, n=6) and omnivores (O, n=16), vegans (∇, n=6) had significantly lower serum
25OHD and higher serum PTH concentrations throughout the year.
b) Bone mineral density (BMD, g/m2, mean+SEM) did not change significantly according to seasons over
the study period neither in the lumbar spine (upper panel) or in the femoral neck (lower panel) in the
studied groups. In both sites lowest BMDs were found in vegans (∇, n=6) and highest in omnivores (O,
n=16,  =lacto-vegetarians, n=6).
The effect of 11 months of ergocalciferol supplementation on bone metabolism of
vegetarians (study IV)
The yearly mean dietary vitamin D intake differed significantly among the vegetarians
and omnivores (p<0.001), and was lower in the vegans and lacto-vegetarians as
compared to the omnivores (p<0.05, Table 5.1.). Dietary calcium intake did not differ
significantly among the groups (p=0.28, Table 5.1.). Probably due to the small sample
sizes the differences among the groups in serum 25OHD concentrations (vegans:27+5
nmol/l, lacto-vegetarians:34+20 nmol/l, omnivores:39+18 nmol/l, p=0.30) and serum
PTH concentrations (vegans:47+14 ng/l, lacto-vegetarians:41+21 ng/l, omnivores:27+14
ng/l, p=0.08) did not reach statistical significances at the beginning (April 1995) of the
study. During ergocalciferol supplementation (5 µg/d) serum 25OHD concentrations
increased significantly in all groups (vegans:37+15 nmol/l, p=0.01, lacto-
vegetarians:31+19 nmol/l, p=0.02, omnivores:19+19 nmol/l, p=0.01), and the changes
tended to differ among the groups (p=0.17). Moreover, changes seen in serum PTH
concentration tended to differ among the groups (vegans:-5+11 ng/l, lacto-vegetarians:
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-4+19 ng/l, omnivores:+7+10 ng/l, p=0.17). Changes seen in the urinary calcium
excretion did not differ significantly among the groups (vegans:1.80+2.01 mmol, lacto-
vegetarians:1.78+2.07 mmol, omnivores:1.02+0.86 mmol, p=0.54), but the increase
seen within the groups was significant in omnivores (p=0.01) and tended to be
significant in vegans (p=0.12) and lacto-vegetarians (p=0.13). The percentage changes
in lumbar spine and in femoral neck BMD in the study groups are presented in Figure
5.4. Interestingly, despite vitamin D supplementation one vegan with the lowest mean
daily calcium intake of 350 mg had an approximately 5% decrease in both lumbar spine
and in femoral neck BMD during the study (Figure 5.4.). However, she was the only
vegan in which lumbar spine density decreased.
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Figure 5.4. The percentage changes in lumbar spine and femoral neck BMD in the study groups. Precision
of the DEXA measurement in the lumbar spine (0.9%) and in the femoral neck (1.2%) is presented with
dotted lines. (¤=vegan with calcium intake of 350 mg/d, *=omnivores that had been in sunny areas abroad
or used vitamin D supplements; ∇=vegans, n=5; O=omnivores, n=10; =lacto-vegetarians, n=5).
Bioavailability of vitamin D from edible mushrooms (Cantharellus tubaeformis) by
developed human bioassay (study V)
In this bioassay the increase in serum 25OHD concentration was used as an indicator of
vitamin D bioavailability. At the beginning of the three-week study, the mean values of
the serum 25OHD concentrations were within the reference range and did not differ
among the groups (p=0.28, Figure 5.5.). When all the groups were considered, the serum
25OHD concentrations showed different time-related changes among the groups during
the study (pgroup=0.39, ptime<0.001, pgroup*time<0.001). When the initial values were used
as covariates, the final values of the serum 25OHD concentration differed significantly
among the groups (p=0.01). Moreover, the analysis of covariance revealed that  the final
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values of the serum 25OHD concentrations differed significantly between group 1
(received mushrooms) and group 3 (not supplemented, p=0.03) as well as between
group 2 (received supplement) and group 3 (p=0.01) when the initial values were used
as covariates. However, the final values of the serum 25OHD concentrations did not
differ between group 1 and group 2 (p=0.32). The serum PTH concentrations did not
change significantly over the study among the groups (pgroup=0.24, ptime=0.97,
pgroup*time=0.96). The strontium absorption, which reflects calcium absorption, did not
differ among the groups during the study (pgroup=0.96, ptime=0.08, pgroup*time=0.40).
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Figure 5.5. Changes seen in serum 25OHD concentrations (nmol/l,  mean+SEM) during the three-week
study in the subjects who consumed mushrooms ( =group 1), ergocalciferol supplement (=group 2) or
no supplement (=group 3). At the beginning of the study the mean values of serum 25OHD
concentrations did not differ between the groups (p=0.28). Serum 25OHD concentrations increased during
the supplementation both in the group having mushrooms and in that having supplement, and differed
significantly from the group which had no supplementation (group 1 vs group 3: p=0.03; group 2 vs group
3: p=0.01).
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6. Discussion
General discussion
In this study the vitamin D, calcium and bone metabolism in adolescents, young adults
and premenopausal female vegetarians was investigated. Also, the biovailability of
vitamin D from wild edible mushrooms, Cantharellus tubaeformis, was evaluated in a
semi-controlled setting, in which the dietary and supplemental vitamin D intakes of the
subjects were controlled.
Serum 25OHD and PTH are important regulators of bone metabolism, but the effect of
low vitamin status and elevated PTH concentrations on bone metabolism has not been
evaluated in cross-sectional studies in adolescents and young adults. Population-based
studies in adolescents and adults were conducted at the end of winter (February-March)
when serum vitamin D concentrations are lowest. A vegetarian lifestyle increases the
risk for vitamin D deficiency during winter when the exposure to sunlight is limited. In
a longitudinal study the effect of low vitamin D status and ergocalciferol
supplementation on calcium and bone metabolism of premenopausal vegetarians was
evaluated. The weakness of the vegetarian study was the small number of subjects, and
the findings are preliminary.
Dietary vitamin D intake and serum 25OHD concentrations
In line with recent studies (The Findiet 1997 Study Group 1998, Lehtonen-Veromaa et
al 1999) our study confirmed that the mean dietary vitamin D intake almost met the
recommendations (5 µg/d, 200 IU, National Nutrition Council 1998) in adolescents
females and males as well as in adult females. The mean dietary vitamin D intake of
adult males exceeded the recommendations. In vegetarians the dietary vitamin D intake
was, as has been shown in earlier studies (Lamberg-Allardt et al 1993, Outila et al
1998), far from recommended. Dietary vitamin D intake was estimated by a food
frequency questionnaire previously used in dietary studies (Seppänen et al 1993,
Välimäki et al 1994, Outila et al 1998). Generally, serum 25OHD concentration is used
as an indicator of vitamin D status. In all the substudies dietary vitamin D intake
correlated positively with serum 25OHD concentration. Also, in all the study groups
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higher serum 25OHD concentrations were found in subjects with increased
supplemental vitamin D intakes and prolonged sunlight exposure.
The main outcome of our studies was that regardless of the fact that the mean dietary
vitamin D intake practically fulfilled the recommendations, a large percentage of
adolescents and adults had low serum 25OHD levels during winter. Approximately 14%
of adolescents and 27% of adults were vitamin D deficient (having serum 25OHD
concentration less than 25 nmol/l), which confirms earlier studies in Finland (Parviainen
and Koskinen 1983, Ala-Houhala et al 1984, Lamberg-Allardt et al 1986, Lehtonen-
Veromaa 1999). Also, as reported earlier (Lamberg-Allardt et al 1993), low serum
25OHD levels were found in the vegans and lacto-vegetarians in the winter. Moreover,
in vegetarians serum 25OHD concentration showed seasonal variation with higher
values during the summer.
Serum 25OHD and PTH concentrations
A significant inverse relationship was found between serum 25OHD and PTH
concentrations in all studied groups. In our population-based studies the determination
of low vitamin D status was achieved by studying the relationship between 25OHD and
PTH concentration. Thus, the lower limit for adequate vitamin D status was the serum
25OHD concentration at which PTH concentration was in its minimum or a plateau was
reached. This level was reached at serum 25OHD concentrations higher than 40 nmol/l
in adolescent females and males. Among the adults serum PTH concentrations started to
increase with serum 25OHD concentrations lower than 80 nmol/l in females and lower
than 40 nmol/l in males, respectively. In earlier studies the different genders have not
been analysed separately, and our results show that as compared to males, higher serum
25OHD concentrations are needed to maintain serum PTH concentrations low during
the winter among healthy young females, which could have deleterious effects
especially on female bone metabolism in the long run. Also, the adult females had
significantly higher mean serum PTH concentration than males, and in the females
serum 25OHD was an important predictor of the serum PTH concentration suggesting
that especially in the females vitamin D deficiency was associated with elevated serum
PTH concentration. Based on the relationship between serum 25OHD and PTH
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concentrations, on an average 60 % of adolescents and 70 % of adults had low
vitamin D status in southern Finland.
Earlier studies done mainly using elderly subjects suggest that serum 25OHD
concentrations as high as 75-100 nmol/l are needed to keep serum PTH concentration
low (Chapuy et al 1997, Kinuamy et al 1998). However, this definition cannot be used
in other age groups as PTH could be regulated differently at different ages. Also, it is
well known that serum PTH often reaches levels above the reference limit in the elderly,
but according to our study secondary hyperparathyroidism was uncommon both in
adolescents and adults regardless of low serum 25OHD concentrations. Thus, our results
suggest that the regulation of PTH secretion is better controlled in adolescents and
younger adults than in the elderly. This could be due to the fact that in both groups the
mean dietary calcium intake was adequate. In addition, reference ranges are set for
healthy adults, not for growing adolescents. Earlier Guillemant et al (1995) speculated
that as compared to the situation in adulthood, during adolescence different
physiological mechanisms regulate the secretion of PTH. As reported earlier (Krabbe et
al 1982, Cadogan et al 1998), our results also suggest that during puberty, age and
height velocity are strongly associated with serum PTH concentration. However, in
premenopausal vegans suffering from vitamin D deficiency serum PTH values exceeded
the upper reference limit during winter. It should be noted that especially in vegan diet
the bioavailability of calcium may be low as absorption of calcium from plant sources is
decreased. Also, in line with earlier findings in postmenopausal women (Lips et al 1983,
Krall et al 1989) serum PTH concentrations showed seasonal variations in the
vegetarians.
Vitamin D status and bone mineral density
Lumbar spine BMD was lower in vegans than in omnivores. The results from the
vegetarian study showed that a low serum 25OHD concentration is associated with a
high serum PTH concentration which predicted lower BMD especially in the vegans.
Earlier, Khaw et al (1992) suggested that the effects of low serum 25OHD
concentrations on bone metabolism may be mediated through serum PTH
concentrations in middle aged women and our results agree with their data. These
findings support the hypothesis that prolonged vitamin D deficiency has deleterious
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effects on the bone metabolism of young adults. However, the effect of low vitamin D
status has not been studied properly in population-based samples. The study among
adolescents revealed that lower forearm BMD was found in female adolescents with
serum 25OHD concentration lower than 40 nmol/l (based on the relationship between
serum 25OHD and PTH concentrations). Thus, our results suggest that in order to keep
bone turnover in balance throughout the year and to reach the maximal peak bone mass
during puberty, among the adolescents serum 25OHD concentrations should be higher
than 40 nmol/l around the year. Interestingly, earlier Docio et al (1998) suggested that
the threshold for vitamin D deficiency in children (7-10 yr) may be between 30-50
nmol/l. However, in the regression analysis age, BMI, exercise and height velocity
appeared to be stronger determinants of BMD in growing adolescents than vitamin D
status. The strong positive effect of exercise on growing skeleton has been earlier
reported among the adolescents (Välimäki et al 1994). In the adults the means of
measured BMD sites did not differ significantly among the groups categorised by low
vitamin D status, but as a consequence of a low vitamin D status elevated serum PTH
concentrations predicted lower BMD in the forearm of both adult females and males.
The effect of vitamin D supplementation on bone metabolism
Our study showed that 11 months of ergocalciferol (5 µg/d, 200 IU/d) supplementation
tended to increase BMD in premenopausal female vegans suffering from vitamin D
deficiency during winter. The role of vitamin D supplementation in the prevention of
bone loss and hip fractures among the elderly is well known (for a review see Compston
1995). In this study we have suggested that vitamin D supplementation has beneficial
effects on calcium and bone metabolism also in younger subjects suffering from vitamin
D deficiency. However, the increases could have been higher if the vegans had been
given calcium supplements in addition to ergocalciferol or if the daily vitamin D
supplementation had been greater. In addition, recent studies have suggested that
cholecalciferol, D3, increases serum 25OHD concentration more effectively than
ergocalciferol, D2 (Trang et al 1998). Thus, the positive changes seen in serum 25OHD
concentrations and in bone metabolism could have been stronger if cholecalciferol
supplementation had been given instead of ergocalciferol.
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Method for measuring the bioavailability of vitamin D
In humans the bioavailability of vitamin D has been studied so far from supplements,
not from natural food sources. In supplementation studies the dose of vitamin D has
been comparatively high, and the serum response of native vitamin D, which has a short
half-life, could be measured only after a few hours. In natural foods, vitamin D content
is comparatively low and thus the serum response of native vitamin D cannot be
measured. Also, other vitamin D metabolites could contribute to the total vitamin D
activity of the foodstuff (for a review see van den Berg 1997). In this study we
developed a human bioassay for vitamin D bioavailability studies. In our method the
increase in serum 25OHD concentration is used as an indicator of vitamin D
bioavailability. Serum 25OHD concentration is a major metabolite of vitamin D in the
circulation and other metabolites cannot be considered important markers of vitamin D
status. In the study setting developed in this study, the basal concentration of 25OHD
has to be comparatively low. The response of 25OHD is not immediate and thus the
experiment has to be carried out for a few weeks.
The bioavailability of vitamin D from mushrooms
In Finland natural dietary vitamin D sources are scarce, and fish and vitaminised
margarines form 70-80% of the daily dietary vitamin D intake (Lamberg-Allardt 1984,
Mattila 1995). In addition, some wild mushrooms, especially Cantharellus tubaeformis,
contains high amounts (29.8 µg/100 g of fresh weight) of ergocalciferol (Mattila et al
1994). Thus, for some groups, such as vegetarians or persons allergic to fish, wild
mushrooms could be important natural dietary sources of vitamin D. Using the new
bioassay for human bioavailability studies we showed for the first time that
ergocalciferol in mushrooms increased the serum 25OHD concentration as effectively as
the ergocalciferol supplement, and the bioassay developed can be conveniently used for
vitamin D bioavailability studies in humans. A significant difference was seen between
the control and the groups receiving mushrooms or supplement already after 1.5 weeks
of supplementation, which seemed to reach a plateau during the next 1.5 weeks of
supplementation. Our study agrees well with earlier studies suggesting that three weeks
10 µg/d supplementation is enough to elevate serum 25OHD concentrations to
significantly higher levels compared to controls (Lips et al 1988, Dubbelman et al
1993).
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7. Conclusions
Regardless of the fact that the mean dietary vitamin D intake practically fulfilled the
recommendations, a large percentage of adolescent and adult populations had low
vitamin D status during winter in Finland. These studies suggest that decreased
wintertime vitamin D status negatively affects the bone metabolism of healthy
adolescent and adult populations as well as vegetarians. However, vitamin D
supplementation seemed to normalise the disturbances seen in calcium and bone
metabolism in vegetarians. Thus, in cases when dietary vitamin D intake is too low,
vitamin D supplementation is recommended for adolescents, adults and vegetarians
during winter. An edible mushroom, Cantharellus tubaeformis, appears to be a good
natural vitamin D source especially for vegetarians. Selection of foodstuffs fortified
with vitamin D could also be broadened. Also, when determining the adequate vitamin
D status, the reference ranges for different age groups should be considered. Moreover,
the bioavailability of vitamin D from dietary sources can be conveniently studied in
humans with the bioassay developed.
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8. Summary
1. On an average ~14% of adolescent population in southern Finland had serum 25OHD
concentrations lower than 25 nmol/l in the winter indicating that a relatively large
percentage of adolescents suffer from vitamin D deficiency during the winter. Based on
the relation between serum 25OHD and PTH concentrations, ~60% of the adolescent
females and males had low vitamin D status (serum 25OHD concentration less than 40
nmol/l). Although serum 25OHD and PTH concentrations correlated inversely,
secondary hyperparathyroidism was uncommon. The effect of low vitamin D status on
the growing skeleton has not been studied earlier, and our results show that in growing
females low vitamin D status (serum 25OHD concentration less than 40 nmol/l) is
associated with low forearm radius BMD and tended to be associated with ulna BMD.
However, the effects of low vitamin D status on growing skeleton should be further
evaluated in an intervention study.
On an average ~27 % of adult Finnish population in southern Finland were vitamin D
deficient, having serum 25OHD concentration less than 25 nmol/l. Based on the relation
between serum 25OHD and PTH, ~86 % of the adult females (serum 25OHD
concentration less than 80 nmol/l) and ~56 % of the males (serum 25OHD concentration
less than 40 nmol/l) had low vitamin D status during the winter. Regardless of the fact
that elevated serum PTH concentrations were found in the subjects with low vitamin D
status, secondary hyperparathyroidism was uncommon. Elevated serum PTH
concentrations predicted in the males and tended to predict in the females lower forearm
BMD. Thus, the effect of vitamin D status on adults BMD should be studied in an
intervention study.
2. Healthy premenopausal vegans suffer from vitamin D deficiency and secondary
hyperparathyroidism at least in the winter at northern latitudes. In addition, vegans had
lower BMD in the lumbar spine than omnivores, which is a risk factor for fractures. The
results also show that vitamin D deficiency states are more pronounced in vegans than
in lacto-vegetarians. The limitation of small sample sizes must not be underestimated,
but regardless of a low number of subjects the results suggest that vitamin D deficiency
has negative effects on vegans BMD in the long run. Thus, an increase in vitamin D
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intake either by dietary means or by supplementation should generally be recommended
for vegans at least during winter. In addition, the selections of foodstuffs fortified with
vitamin D should be broadened.
3. Eleven months of ergocalciferol supplementation (5 µg/d, 200 IU/d) tended to
increase lumbar spine BMD among vegans suffering from vitamin D deficiency during
winter and with a lower lumbar spine BMD than omnivores. However, probably due to
the small number of subjects, the short supplementation period or inadequate
supplementation dose levels of statistical significance were not reached, and the findings
are preliminary. Thus, further studies are needed to verify our results.
4. Ergocalciferol was well absorbed from lyophilised and homogenised wild mushrooms
in man, and the bioavailability of vitamin D from dietary sources can be conveniently
studied in humans with the experimental protocol developed. Thus, mushrooms can be
reliably recommended to be enjoyed as a natural vitamin D source for example by
vegetarians, but the bioavailability of vitamin D from fresh, non-lyophilised mushrooms
as well as from fish has to be evaluated.
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